Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Big Pharma's patent monopoly is stealing your paycheck - and driving up costs
A tsunami of healthcare costs is crashing into the budgets of U.S. businesses. Each new wave forces employers to devote more resources to healthcare and fewer to employee wages, benefits, and investments for growth. Beyond the workplace, families…
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Consensus Rating of 'Moderate Buy' by Brokerages
Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) have received an average rating of 'Moderate Buy' from the thirteen analysts that are presently covering the stock, MarketBeat Ratings reports. One research analyst has…
Dutch ambassador visits survivors of fatal Swiss coach accident
Switzerland juggles fighting crime against threat to tech-privacy industry Read more: Switzerland juggles fighting crime against threat to tech-privacy industry US-Canada trade war escalates, 9/11 25 years on, and a medical first involving a pig…
AutoZone: The Business Held Up, The Valuation Did Not (NYSE:AZO)
AutoZone remains a Buy, now driven by compressed valuation and moderate earnings growth rather than expectations of rapid margin normalization. Revenue growth exceeded expectations, with commercial sales up 10% and the store base surpassing 8,000…
Donald Trump says he would 'love' to see united Ireland
Donald Trump has said he would “love” to see a united Ireland and that it “may as well happen now”. The US president appeared to endorse the push for constitutional change on the island at the start of a two-day visit to…
Movers & Shakers: Stocks that will see action this week
Allied Blenders and Distillers (₹631.85) The stock of Allied Blenders and Distillers has been charting a sideways trend since mid-July, where it has been oscillating between ₹585 and ₹650. Nevertheless, the broader trend…
Acutaas Chemicals: Offering multi-vertical growth runway
Acutaas Chemicals has delivered close to 6x returns since its IPO in 2021, supported by a 31 per cent revenue CAGR and 45 per cent EPS CAGR over FY21-26. On the product front, the company has expanded beyond its core advanced pharma intermediates…
How Much Do You Really Need Invested in Bristol Myers Squibb to Collect $10,000 a Year?
The exercise is simple: how large a position in Bristol Myers Squibb (NYSE:BMY | BMY Price Prediction) do you need to throw off $10,000 a year in dividend income? Start with the income target and solve backward, using the live yield and the live…
Vuelta a España: Enric Mas passes arduous final mountain test to keep red as Mikel Landa soars to stage 20 breakaway victory atop Collado del Alguacil
Enric Mas (Movistar) put the finishing touches on a certain Vuelta a España victory atop the steep slopes of the Collado de Alguacil, the Spaniard surviving a day of long-range GC action to hold onto the red jersey after five hours of…
Kimberly-Clark's 54-Year Dividend Streak Faces Its Biggest Test Yet With $48.7 Billion Kenvue Deal
Kimberly-Clark just raised its dividend for the 54th straight year while simultaneously chasing a nearly $50 billion acquisition, and income investors are now weighing whether a deal of that size can coexist with a payout that costs over $1.6…
National Pension Service Acquires 112,357 Shares of Teva Pharmaceutical Industries Ltd. $TEVA
National Pension Service increased its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 4.9% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional…
Streeterville Cannabis Shop Permit Upheld by Judge
A Cook County judge has upheld the City of Chicago's approval for Guaranteed Dispensary to operate at the southwest corner of Ontario Street and Fairbanks Court in Streeterville, ending — at least for now — a bitter fight over whether…
Pfizer (NYSE:PFE) Rating Increased to Buy at Wall Street Zen
Pfizer (NYSE:PFE - Get Free Report) was upgraded by analysts at Wall Street Zen from a 'hold' rating to a 'buy' rating in a note issued to investors on Sunday, Wall Street Zen reports. The Phase 3 Failure That Sent Biotech Winners and Losers in…
How Much Do You Really Need Invested in Dividend Stocks to Replace a $25,000 Income?
The goal here is $25,000 a year in dividend income. Working backward from a paycheck number is more useful than starting with a lump sum because it forces the question every income investor eventually asks: what is the price of admission at each…
DexCom, Inc. $DXCM Position Cut by Baird Financial Group Inc.
Baird Financial Group Inc. reduced its holdings in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 36.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned…
Receive a Daily briefing on Pharma Industry News
Get Started